Eikon Therapeutics, Inc. (EIKN) Form 10-K Annual Reports
Eikon Therapeutics, Inc. (EIKN) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: EIKN
CIK: 1861123
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerGraham Poles
Audit LocationSan Jose, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-10-07 | — | SCHEDULE 13G/A Filing | 0000315066-26-002331 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-10-02 | — | SCHEDULE 13G/A Filing | 0001104659-26-113112 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-03 | 4 | 0001193125-26-385268 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-13 | 8-K | 0001193125-26-349936 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001193125-26-349185 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001193125-26-349154 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-001987 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-07-31 | 8-K | 0001193125-26-330710 | View SEC Doc Filr Page |
| 3 | 2026-06-15 | 2026-06-15 | 3 | 0001193125-26-271167 | View SEC Doc Filr Page |
| 8-K | 2026-06-10 | 2026-06-05 | 8-K | 0001193125-26-265861 | View SEC Doc Filr Page |
| 8-K | 2026-06-01 | 2026-05-30 | 8-K | 0001193125-26-249725 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0001720215-26-000006 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-13 | — | SCHEDULE 13G Filing | 0001193125-26-221988 | View SEC Doc Filr Page |
| 10-Q | 2026-05-11 | 2026-03-31 | 10-Q | 0001193125-26-216791 | View SEC Doc Filr Page |
| 8-K | 2026-05-11 | 2026-05-11 | 8-K | 0001193125-26-216744 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-06 | — | SCHEDULE 13G Filing | 0000315066-26-001183 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-29 | — | SCHEDULE 13G Filing | 0002052113-26-000458 | View SEC Doc Filr Page |
| 8-K | 2026-03-30 | 2026-03-30 | 8-K | 0001193125-26-130449 | View SEC Doc Filr Page |
| 10-K | 2026-03-30 | 2025-12-31 | 10-K | 0001193125-26-130395 | View SEC Doc Filr Page |
| 4 | 2026-03-04 | 2026-03-02 | 4 | 0001193125-26-091798 | View SEC Doc Filr Page |
| 4 | 2026-03-04 | 2026-03-02 | 4 | 0001193125-26-091787 | View SEC Doc Filr Page |
| 4 | 2026-03-04 | 2026-03-02 | 4 | 0001193125-26-091783 | View SEC Doc Filr Page |
| 4 | 2026-03-04 | 2026-03-02 | 4 | 0001193125-26-091779 | View SEC Doc Filr Page |
| 4 | 2026-03-04 | 2026-03-02 | 4 | 0001193125-26-091771 | View SEC Doc Filr Page |
| 4 | 2026-03-04 | 2026-03-02 | 4 | 0001193125-26-091770 | View SEC Doc Filr Page |